Evidence map›Paper›PMID 41407390›Full record

ReviewEuropean respiratory review : an official journal of the European Respiratory Society2025

High-flow nasal cannula in severe asthma exacerbations: current evidence and clinical perspectives.

Lorenzo Carriera, Simone Ielo, Roberto Barone, Roberto Lipsi, Angelo Coppola, Andrea Smargiassi, Riccardo Inchingolo, Luca Richeldi, Raffaele Scala

Abstract readReview
In one paragraph

Review in European respiratory review : an official journal of the European Respiratory Society, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Lorenzo CarrieraFacoltà di Medicina e Chirurgia, Università Cattolica del Sacro Cuore, Rome, Italy lorenzo.carriera01@icatt.it.ORCID https://orcid.org/0009-0006-2538-1278
Simone IeloFacoltà di Medicina e Chirurgia, Università Cattolica del Sacro Cuore, Rome, Italy.ORCID https://orcid.org/0009-0002-2838-423X
Roberto BaroneFacoltà di Medicina e Chirurgia, Università Cattolica del Sacro Cuore, Rome, Italy.
Roberto LipsiDepartment of Pulmonology and Sub-Intensive Respiratory Unit, Ospedale Santa Maria della Misericordia, Perugia, Italy.
Angelo CoppolaDepartment of Pulmonology and Sub-Intensive Respiratory Unit, Ospedale San Filippo Neri-ASL Roma 1, Rome, Italy.
Andrea SmargiassiUOC Pneumologia, Dipartimento Neuroscienze, Organi di Senso e Torace, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.ORCID https://orcid.org/0000-0003-0637-7282
Riccardo InchingoloUOC Pneumologia, Dipartimento Neuroscienze, Organi di Senso e Torace, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.
Luca RicheldiFacoltà di Medicina e Chirurgia, Università Cattolica del Sacro Cuore, Rome, Italy.
Raffaele ScalaUOC Pneumologia e UTIP, Ospedale San Donato, USL Toscana SudESt, Arezzo, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The management of asthma exacerbations is well established, including inhaled short-acting β

Indexed as

AsthmaCannulaLungNoninvasive VentilationOxygen Inhalation TherapyAdministration, InhalationDisease ProgressionEquipment DesignHumansRecovery of FunctionRisk FactorsSeverity of Illness IndexTreatment Outcome

Identifiers

PMID41407390
PMCPMC12709364

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.